This enhancement is primarily attributed to the induction of robust CD4+ and CD8+ T-cell mediated immune responses, which include antigen-specific multifunctional T-cells and IFN-γ-secreting cells, crucial for the efficacy of TB vaccines [12,15–18]. The gene discussed is IFNG; the disease is tuberculosis.